©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10451-10466
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10451
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10451
Table 5 Scores of risk factors in the survival prognosis model of advanced gastric signet ring cell carcinoma
| Variable | Points | Total points | 3/5-yr survival | Total points |
| Age (yr) | 0-56 | 0.9-1 | 0-33 | |
| < 40 | 0 | 56-111 | 0.8-0.9 | 33-88 |
| 40-60 | 18 | 111-146 | 0.7-0.8 | 33-123 |
| 60-80 | 36 | 146-172 | 0.6-0.7 | 123-149 |
| > 80 | 60 | 172-195 | 0.5-0.6 | 149-172 |
| Race | 195-215 | 0.4-0.5 | 172-192 | |
| White | 15 | 215-235 | 0.3-0.4 | 192-212 |
| Black | 37 | 235-257 | 0.2-0.3 | 212-234 |
| Black-AI | 92 | 257-283 | 0.1-0.2 | 234-260 |
| Black-API | 0 | > 283 | < 0.1 | > 260 |
| Tumor size (cm) | ||||
| < 2 | 0 | |||
| 2-5 | 5 | |||
| > 5 | 31 | |||
| NA | 42 | |||
| AJCC stage | ||||
| I | 0 | |||
| II | 54 | |||
| III | 100 | |||
| T stage | ||||
| T2 | 0 | |||
| T3 | 41 | |||
| T4 | 67 | |||
| Adjuvant therapy | ||||
| Radiotherapy | 33 | |||
| Chemotherapy | 10 | |||
| Radiotherapy + Chemotherapy | 0 | |||
| None | 67 |
- Citation: Tian HK, Zhang Z, Ning ZK, Liu J, Liu ZT, Huang HY, Zong Z, Li H. Clinicopathological characteristics and prognosis of gastric signet ring cell carcinoma. World J Clin Cases 2022; 10(29): 10451-10466
- URL: https://www.wjgnet.com/2307-8960/full/v10/i29/10451.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i29.10451